FDA Investigator Guerlain Ulysse

Guerlain Ulysse has conducted inspections on 85 sites in 9 countries as of 11 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
85
Last Inspection Date:
11 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Italy, United Kingdom of Great Britain and Northern Ireland, India, Netherlands, Indonesia, Germany, Korea (Republic of), Switzerland
FDA Investigators that have inspected at least one site in common with Guerlain Ulysse:
Addam S Reynolds, Adetutu M Gidado, Aditi S Thakur, Alan P Kurtzberg, Alanna L Mussawwir Bias, Alberto A Viciedo, Alice S Tsao, Alison N Stieg, Allen Lou, Amatul H Marium, Amy L Singer, Amy M Cramer, Anastasia I Onuorah, Anastasia M Shields, Andrea Siegel, PhD, Ankur C Patel, Ann Marie Montemurro, Anna M Brannen, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Anthony J Donato, Arsen Karapetyan, Atul J Agrawal, Azza Talaat, Bapu R Gaddam, Barbara J Maulfair, Barbara Jwilimczyk Macri, Bei Yu, Benton M Ketron, Bijoy Panicker, Bo Chi, PhD, Bonita S Chester, Brandy N Lepage, Brooke K Higgins, Brooke K Seeman, Bryan L Mcguckin, Byungja E Marciante, Camerson E Moore, Candace Y Gomez Broughton, Carrie A Hughes, Cary Greene, Caryn M Mcnab, Cassandra L Abellard, CDR Ileana Barreto Pettit, Chaltu Nwakijra, Charanjeet Jassal, Charisse K Green, Charles J Chacko, Charles R Cote, RIC, Charles Yuanchia Kuo, PhD, Cheryl A Grandinetti, Christina N Maurino, Christina P Burkhart, Christine M Cerenzio, Craig W Swanson, Crystal A Harlan, Cynthia F Kleppinger, MD, Cynthia Jim, CSO, Dale A Nyberg, Daniel J Grabicki, David D Anderson, PhD, David R Delucia, Dawn C Olenjack, Dawn L Wydner, Deborah B Nixon, Deborah J Parris, Debra I Love, Debra L Pagano, Demitria J Xiradakis, Denise M Digiulio, Denise M Visco, Investigator, Dennis Cantellops Paite, Dennis E Guilfoyle, PhD, Dennis L Doupnik, Dhaval H Patel, Diane T Bargo, Diane T O'brien, Dinesh Kumar, Dipesh K Shah, Doan T Nguyen, PharmD, Douglas A Campbell, Douglas C Kovacs, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Dr. Willie Wilson, PhD, Dr. Zhihao Qiu (Peter), PhD, Edmund F Mrak, Jr, Emest F Bizjak, Emmanuel Jramos Maldonado, Eric J Cunningham, Eric L Dong, BS, Eric Rothschild, Erin D Mccaffery, Esteban Beltran, Farhana Khan, Felix Maldonado, Frank J Marciniak, Frank Wackes, Frederick F Razzaghi, Gabrielle J Swain, Gam S Zamil, Gary J Lehr, Gary T Greco, George Pyramides, Gerard Pde Leon, Gianine E Delade, Gianine E Tompkins, Gobiga Vanniyasingam, Gregson A Joseph, Gunther Boekhoudt, PhD, Guo Q Shen, Haitao Li, Helen B Ricalde, Helen Verdel, Herbert M Corbello, Ivy E Sweeney, J Paul Kirwan, PhD, Jacqueline Mdiaz Albertini, James A Liubicich, James C Maclaughlin, James L Dunnie, Jr, James M Mason, James R Birkenstamm, Janet A Rajan, Jason M Sluzynski, Javier E Santos, Jawaid Hamid, Jay T Wong, Jean M Kelahan, Jean M Mulinde, MD, Jeffery B Medwid, PhD, Jeffrey P Raimondi, Jenny Sung, Jens Fricke, Jeremy W Rotton, Jessica M Monteiro, Jessica S Estriplet, Joan A Loreng, Jogy George, John P Mistler, Johnna L Bleem, Jonah S Ufferfilge, Jonathan S Helfgott, Jonathan W Chapman, Jonee J Mearns, Jose A Lopez, Jose Acruz Gonzalez, Jose M Cayuela, Jose Ohernandez Guzman, Joseph F Mcginnis, RPh, Josh Renzo N Ramilo, Joshua P Wireman, Joy Rkozlowski Klena, Juan Rjimenez Garcia, Juanita P Versace, June P Page, Junho Pak, Justin A Boyd, Justine Tomasso, Kalavati Suvarna, PhD, Kara A Scheibner, PhD, Karen E D'orazio, Karen L Kosar, Karishma G Gopaul, Kassa Ayalew, MD, Katelyn Astaub Zamperini, Kathleen M Jordan, Keith M Reilly, Kelli F Dobilas, Kelli Regente, Kellia N Hicks, Kellie Leveille, Kevin A Gonzalez, Kham Phommachanh, Kinh Q Mac, Ko U Min, Krishnaiah Yellela, Kristy A Zielny, Krystal O Ogunremi, Kshitij A Patkar, Kumar G Janoria, Laishan L Lam, Lakecha N Lewis, Lakshmi Narasimhan, PhD, Lance Mde Souza, MBA, Larry K Austin, Lata C Mathew, PhD, Latorie S Jones, Laura Fontan, MS, Lauren L Vajo, Lawrence J Stringer, Lawrence R Johnson, Lawrence W Farina, LCDR Chad N Thompson, Leiyun Boone, PhD, Li Li, Liatte Kreuger, PharmD, Libia M Lugo, Linda F Murphy, Lisa Harlan, Loretta Nemchik, Lucila B Nwatu, Luis A Dasta, Madushini Dharmasena, PhD, Maotang Zhou, PhD, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marcia D Fields, Marcus A Ray, Marea K Harmon, Margaret E Sarles, Margaret M Annes, Margaret M Sands, Maria Estrella, Maria Joselopez Barragan, PhD, Maria Manzoni, PhD, Marlene G Swider, Massoud Motamed, Matthew A Spataro, Maxwell Van Tassell, PhD, Mayar M Mussa, Meisha R Sampson, Meisha Waters, Melba Trivera Clavell, Melissa B Libby, Melissa J Garcia, Melissa M Dauksis, Melissa M Schafer, Melissa T Roy, Meredith L Sheridan, Meredith P Soehl, Investigator, Merril E Racke, Meyer J Slobotsky, Michael A Charles, Michael A Taylor, Michael D Omeara, Michael L Casner, Michael L Chasey, Michael Levin, Michael O Idowu, Michael R Dominick, Michael R Klapal, Michael Serrano, Michele Gottshall, Michele Perry Williams, Michelle Marsh, Michelle Yclark Stuart, Milos Dokmanovic, PhD, Mindy M Chou, Monika Borkowska, Mra Davism, Muralidhara B Gavini, PhD, Nailing Zhang, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Natasha Gupta, Nayan J Patel, Nazmul Hassan, Neil J Bonzagni, PhD MPH, Nerizza B Guerin, Nicholas A Violand, Nicole E Knowlton, Niketa Patel, Nikki S Ramirez, Nina Yang, Ogechi C Nna, Omotunde O Osunsanmi, Pankaj H Amin, Parul M Patel, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Paul A Bonneau, Paul L Bellamy, Paul Mouris, Paula J Bretz, Perry T Nichols, Peter R Lenahan, Philip F Istafanos, DMV, MS, Prabhu P Raju, Pratik S Upadhyay, DDC, Qin Xu, Rabin N Ghoshal, Rachael A Moliver, Raihan A Chowdhury, Rajiv R Srivastava, Ramon A Hernandez, Rebecca E Dombrowski, Regina T Brown, Reyes Candau Chacon, PhD, Richard D Manney, Richard H Penta, Richard Ledwidge (nmi), PhD, Richard W Thornton, Richmond K Yip, Rita K Kabaso, Robert C Steyert, Robert D Tollefsen, Robert J Maffei, Robert J Martin, Robert Jennings, Robert M Barbosa, Robert Sharpnack, Robin P Mathew, Rodney T Allnutt, Roger F Zabinski, Rose Ljean Mary, Russell J Glapion, Sachinkumar V Patel, Saleem A Akhtar, Samina S Khan, Samir C Gala, Samuel Mindaye, Samuel T Walker, Sandra A Boyd, Sandra A Hughes, Sandra D Thompson, Sangeeta M Khurana, PhD, Sarah Kennett, PhD, Satheesh K Podaralla, Satheesh Thomas, Schultz, Sean R Marcsisin, Shahla Parvizi, Sherri J Liu, Shirley S Wen, Sidney B Priesmeyer, Simone E Pitts, Sinai I Davis, Sixto M Mercado Rios, Sneha S Patel, Sony Mathews, Srinivas R Chennamaneni, PhD, Stephanie T Durso, Stephen D Brown, Stephen J Mottola, Stephenie M Ortiz, Steven M Weinman, Steven P Donald, Suchan Kim, Susan M Halsted, Susan M Jackson, Susan M Joseph, Susan P Bruederle, Susanna E Ford, Tamika White, Tamil Arasu, PhD, Tanya R Syffrard, Tara G Bizjak, Tara K Carmody, Tara R Gooen, Tenzin Jangchup, Terry Bridgewater, Thomas J Arista, Thomas J Mooney, Thomas W Nojek, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Tonia F Bernard, Torrance J Slayton, Toyin B Oladimeji, Tracey L Harris, Tressa T Lewis, Truong Xuan Nguyen (Andy), Tyanna N Hadley, Tzanko Stantchev, Uduak M Inokon, Unnee Ranjan, Valerie C Reed, Valerie Reed, Victoria Spivak, Vilmary Negron Rodriguez, Wayne E Seifert, William A Warnick, William J Leonard, William L Bargo, William V Millar, Xiaohan Cai, PhD, Xiaokuang Lai, PhD, Yan Wang, Yvesna C Blaise, Yvette I Henry, Yvette I Johnson, Yvins Dezan, Zakaria I Ganiyu, Zhijin Chen, Zhong Li, PhD, Zhongren Wu

Guerlain Ulysse's Documents

Publish Date Document Type Title
June, 2021 FDA 483 Ascend Laboratories, LLC - Form 483, 2021-06-24
May, 2019 FDA 483 QuVa Pharma, Inc. - Form 483, 2019-05-31
May, 2021 EIR BioSpectra, Inc. - EIR, 2021-05-04
November, 2019 FDA 483 ImClone Systems LLC - Form 483, 2019-11-26
February, 2022 EIR Strides Pharma, Inc - EIR, 2022-02-08
September, 2019 FDA 483 Aspen Oss B.V. - Form 483, 2019-09-13
March, 2017 EIR Hetero USA Inc - EIR, 2017-03-17
July, 2017 FDA 483 LTS Lohmann Therapy Systems Corp. - Form 483, 2017-07-13
September, 2018 FDA 483 GENIC CO.,LTD - Form 483, 2018-09-13
August, 2016 FDA 483 Garonit Pharmaceutical, Inc. - Form 483, 2016-08-26
August, 2015 FDA 483 Actavis Elizabeth LLC - Form 483, 2015-08-27
December, 2016 FDA 483 Actavis Elizabeth LLC - Form 483, 2016-12-05
March, 2016 FDA 483 LEADING PHARMA, LLC - Form 483, 2016-03-11
August, 2022 EIR Hetero Labs Limited - EIR, 2023-11-28
June, 2020 FDA 483 MasterPharm LLC - Form 483, 2020-06-15
February, 2019 FDA 483 LNK International, Inc. - Form 483, 2019-02-08
December, 2018 FDA 483 Unipack LLC - Form 483, 2018-12-18
March, 2019 FDA 483 Torrent Pharmaceuticals Limited - Form 483, 2019-03-19
October, 2021 FDA 483 Regeneron Pharmaceuticals, Inc. - Form 483, 2021-10-25
March, 2022 FDA 483 Laboratorio Italiano Biochimico Farmaceutico Lisapharma SpA - Form 483, 2022-03-23
February, 2022 FDA 483 Strides Pharma, Inc - Form 483, 2022-02-08
September, 2017 FDA 483 Consumer Product Testing Company - Form 483, 2017-09-06
March, 2017 FDA 483 Hetero USA Inc - Form 483, 2017-03-17
March, 2020 EIR Immunomedics, Inc. - EIR, 2020-03-10
July, 2018 FDA 483 Inopak Ltd - Form 483, 2018-07-20
January, 2022 FDA 483 Bi-Coastal Pharma International - Form 483, 2022-01-14
June, 2022 FDA 483 GENERICHEM CORPORATION - Form 483, 2022-06-08
November, 2019 FDA 483 Response ImClone Systems LLC - Form 483R, 2019-12-16
September, 2015 FDA 483 Integrated Analytical Laboratories, LLC. - Form 483, 2015-09-08
September, 2022 FDA 483 MAKSON HEALTH CARE PRIVATE LIMITED - Form 483, 2022-09-29
August, 2022 FDA 483 Apitoria Pharma Private Limited - Form 483, 2022-08-02
May, 2018 FDA 483 Aragen Life Sciences Limited - Form 483, 2018-05-04
November, 2022 FDA 483 Haupt Pharma Wolfratshausen GmbH - Form 483, 2022-11-15
January, 2018 FDA 483 RARITAN PHARMACEUTICALS INCORPORATED - Form 483, 2018-01-08
February, 2019 FDA 483 Response LNK International, Inc. - Form 483R, 2019-03-04
May, 2018 FDA 483 INDOCO REMEDIES LIMITED - Form 483, 2018-05-11
February, 2024 FDA 483 AIRIS PHARMA PRIVATE LIMITED - Form 483, 2024-02-03
February, 2016 EIR Vantage Specialty Ingredients, Inc - EIR, 2023-11-20
February, 2017 FDA 483 Actavis Elizabeth LLC - Form 483, 2017-02-15
August, 2018 FDA 483 Akorn Operating Company LLC (dba Akorn) - Form 483, 2018-08-30
July, 2019 FDA 483 Mylan Pharmaceuticals Inc. - Form 483, 2019-07-25
September, 2019 EIR DSM Nutritional Products AG Zweigniederlassung Werk Sisseln - EIR, 2024-01-18
May, 2022 FDA 483 Akorn Operating Company LLC (dba Akorn) - Form 483, 2022-05-17
March, 2019 FDA 483 MSN LABORATORIES PRIVATE LIMITED - Form 483, 2019-03-08
January, 2018 EIR RARITAN PHARMACEUTICALS INCORPORATED - EIR, 2018-01-08
June, 2021 EIR Ascend Laboratories, LLC - EIR, 2021-06-24
January, 2017 EIR Alvogen, Inc - EIR, 2017-01-18
January, 2018 FDA 483 Response RARITAN PHARMACEUTICALS INCORPORATED - Form 483R, 2018-01-30
January, 2023 FDA 483 SOFIE Co. dba SOFIE - Form 483, 2023-01-20
February, 2019 EIR LNK International, Inc. - EIR, 2019-02-08
March, 2020 FDA 483 Immunomedics, Inc. - Form 483, 2020-03-10
August, 2022 FDA 483 Hetero Labs Limited - Form 483, 2022-08-12
March, 2019 FDA 483 Response Torrent Pharmaceuticals Limited - Form 483R, 2019-04-08
June, 2016 FDA 483 Nutra-Med Packaging - Form 483, 2016-06-29
October, 2020 FDA 483 Unipack LLC - Form 483, 2020-10-16
May, 2024 FDA 483 Calyx Chemicals and Pharmaceuticals Limited - Form 483, 2024-05-17
June, 2024 FDA 483 Sai Life Sciences Limited - Form 483, 2024-06-14
January, 2024 FDA 483 SUMAR BIOTECH LLP - Form 483, 2024-01-12
January, 2024 FDA 483 SUMAR BIOTECH LLP - Form 483, 2024-01-12

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more